Selected Balance Sheet Information

12 Months Ended

Dec. 31, 2023

Selected Balance Sheet Information

Selected Balance Sheet Information

7. Selected Balance Sheet Information

PREPAID EXPENSES AND OTHER CURRENT ASSETS (in thousands):

	December 31,		December 31,
	2023		2022
Prepaid clinical research organizations	$	1,119	$	2,293
Prepaid insurance		496		637
Prepaid manufacturing expenses		491		418
Prepaid consulting, subscriptions and other expenses		180		155
VAT receivable		128		87
Receivable from Grifols		—		144
Total prepaid expsnese and other current assets	$	2,414	$	3,734

Prepaid clinical research organizations (CROs) expense is classified as a current asset. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services. Receivable from Grifols includes amounts due related to research and development tax rebates, VAT and corporate taxes.

PROPERTY AND EQUIPMENT (in thousands)

	December 31,		December 31,
	2023		2022
Computers and office equipment	$	902	$	897
Other property, plant and equipment		417		208
Leasehold improvements		94		94
Software		11		11
		1,424		1,210
Less: accumulated depreciation and amortization		(1,002)		(865)
Total property and equipment, net	$	422	$	345

During the years ended December 31, 2023 and 2022 the Company recognized depreciation expense of $135,000 and 85,000 respectively.

ACCRUED EXPENSES (in thousands)

	December 31,		December 31,
	2023		2022
Accrued clinical consulting services	$	1,700	$	807
Accrued manufacturing costs		843		197
Accrued vendor payments		452		492
Total accrued expesnes	$	2,995	$	1,496

7. Selected Balance Sheet Information – (continued)

ACCRUED EMPLOYEE BENEFITS (in thousands)

	December 31,		December 31,
	2023		2022
Accrued bonus expense	$	1,307	$	1,216
Accrued compensation expense		127		87
Accrued vacation expense		83		100
Total accrued employee benefits	$	1,517	$	1,403